2017
DOI: 10.1016/j.reth.2016.12.004
|View full text |Cite
|
Sign up to set email alerts
|

Enhancement of individual differences in proliferation and differentiation potentials of aged human adipose-derived stem cells

Abstract: BackgroundAdipose-derived stem cells (ASCs) are a robust, multipotent cell source. They are easily obtained and hold promise in many regenerative applications. It is generally considered that the function of somatic stem cells declines with age. Although several studies have examined the effects of donor age on proliferation potential and pluripotency of ASCs, the results of these studies were not consistent.ObjectiveThis study tested whether the donor age affects the yield of ASCs from adipose tissue, as well… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
24
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 33 publications
(33 citation statements)
references
References 52 publications
(55 reference statements)
4
24
0
Order By: Relevance
“…After 5 passages of culture, hASCs retained the trilineage differentiation ability. Our results are consistent with the results of Kawagishi-Hotta et al (2016) Kawagishi-Hotta et al (2017. Specifically, when cultured in osteogenic induction medium, the cells were mineralized with the expression of alkaline phosphatase Golub and Boesze-Battaglia (2007), osteocalcin secretion, and calcium phosphate deposition Lee et al (2013).…”
Section: Discussionsupporting
confidence: 93%
“…After 5 passages of culture, hASCs retained the trilineage differentiation ability. Our results are consistent with the results of Kawagishi-Hotta et al (2016) Kawagishi-Hotta et al (2017. Specifically, when cultured in osteogenic induction medium, the cells were mineralized with the expression of alkaline phosphatase Golub and Boesze-Battaglia (2007), osteocalcin secretion, and calcium phosphate deposition Lee et al (2013).…”
Section: Discussionsupporting
confidence: 93%
“…Commercial SVF preparation systems have previously highlighted the necessity for in-depth analysis of safety profiling, viable cell analysis, and ultimately clinical trials in order to understand and finely tune the action and benefit [27]. The “quality” of fractions and their MSC content may indeed vary from patient to patient [28]; however, so far, when used in various treatment regimens, these differences have not been shown to significantly alter the outcome [29]. SVF or their purified MSC content has been reported in the literature to have potential therapeutic value [30], but a full characterization of component vs. effect is still lacking.…”
Section: Discussionmentioning
confidence: 99%
“…In the present study, we have investigated aging-associated Cdc42 activity in adiposederived MSCs isolated from male rats of different ages and tested the effects of pharmacological inhibition of Cdc42 in MSCs isolated from aged animals. We focused on males in order to exclude gender effects since there is accumulating evidence that age-related alterations of mesenchymal stem cells can be modulated by sex hormones and estrogen decreases Cdc42 activity (Azios et al 2007;Breu et al 2011;Fossett et al 2012;Kawagishi-Hotta et al 2017).…”
Section: Discussionmentioning
confidence: 99%